This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

Vaccination is an important strategy for preventing infections in patients with hematologic malignancies. Hematopoietic cell transplant (HCT) recipients have diminished immunity against vaccine-preventable diseases after transplantation.

The 2012 NCCN Case Manager and Medical Director Program will include various educational platforms, including but not limited to, four webinars on the topics of Lung Cancer, Non-Hodgkin’s Lymphoma, Gynecologic Malignancies, and Communicating with Patients As Goals Change.